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Protocol
AbstrACt
Introduction Age-related loss of muscle mass and 
strength, sarcopaenia, burdens many older adults. The 
process is accelerated with bed rest, protein intakes 
below requirements and the catabolic effect of certain 
illnesses. Thus, acutely ill, hospitalised older adults are 
particularly vulnerable. Protein supplementation can 
preserve muscle mass and/or strength and, combining 
this with resistance exercise training (RT), may have 
additional benefits. Therefore, this study investigates 
the effect of protein supplementation as an addition to 
offering RT among older adults while admitted to the 
geriatric ward and after discharge. This has not previously 
been investigated.
Methods and analysis In a block-randomised, double-
blind, multicentre intervention study, 165 older adults 
above 70 years, fulfilling the eligibility criteria, will be 
included consecutively from three medical departments 
(blocks of n=20, stratified by recruitment site). After 
inclusion, participants will be randomly allocated (1:1) 
to receive either ready-to-drink, protein-enriched, milk-
based supplements (a total of 27.5 g whey protein/day) or 
isoenergetic placebo products (<1.5 g protein/day), twice 
daily as a supplement to their habitual diet. Both groups 
will be offered a standardised RT programme for lower 
extremity muscle strength (daily while hospitalised and 
4×/week after discharge). The study period starts during 
their hospital stay and continues 12 weeks after discharge. 
The primary endpoint is lower extremity muscle strength 
and function (30 s chair-stand-test). Secondary endpoints 
include muscle mass, measures of physical function and 
measures related to cost-effectiveness.
Ethics and dissemination Approval is given by the 
Research Ethic Committee of the Capital Region of 
Denmark (reference no. H-16018240) and the Danish Data 
Protection Agency (reference no. HGH-2016-050). There 
are no expected risks associated with participation, and 
each participant is expected to benefit from the RT. Results 
will be published in peer-reviewed international journals 
and presented at national and international congresses 
and symposiums.
trial registration number NCT02717819 (9 March 2016).
IntroduCtIon
Sarcopenia is the loss of muscle mass and 
strength with ageing. It is an unavoidable 
process with a multifactorial aetiology1 2 asso-
ciated to impaired balance and increased 
risk of falls and mortality.3 Also, sarcopenia 
strengths and limitations of this study
 ► To our knowledge, this is the first study to investigate 
the effect of protein supplementation in addition to 
resistance exercise training (RT) among acutely ill 
geriatric patients while admitted and after discharge, 
and it adds new information to the evidence-based 
healthcare.
 ► The study is randomised and double-blinded 
which  minimises the risk of selection, performance 
and detection bias, and the multicentre trial design 
increases the generalisability of the results.
 ► The lack of supervised RT after discharge might lower 
compliance to the RT, although it is more realistic 
that self-training at home can be implemented in a 
real-world setting.
 ► Acutely ill older adults are a difficult population 
to maintain in a long-duration intervention study, 
which increases the risk of dropouts and/or low 
compliance.
 ► Registration of compliance in dietary studies is 
always associated with a risk of bias, but by asking 
the participants to register their daily intake, save 
empty bottles and by calling them on a weekly basis 
to check on compliance, this is minimised.
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is associated with a threefold to fourfold increased risk 
of disability, which in turn is related to substantial socio-
economic and healthcare spending.4 Acute illness might 
result in stress metabolism that further increases the loss 
of protein and the anabolic resistance in older adults, 
leading to increased loss of lean body mass (LBM),5 and 
this is further accelerated by bed rest during hospitalisa-
tion. Also, many older adults consume relatively small 
amounts of protein, important for maintenance and 
build up of LBM, and loss of appetite as a consequence of 
acute illness may further decrease the protein consump-
tion.6 7 This is very critical, as research has shown that the 
protein requirement increases with age.8 Even a short 
hospital stay increases the risk of losing functional capacity 
and the ability to cope with activities of daily living.9 For 
older medical patients, it has been shown that only one 
in three regained their habitual physical function 1 year 
after discharge.10 Hence, interdisciplinary interventions 
to counteract sarcopenia become even more relevant in 
the acutely ill older patients.
The beneficial effect of resistance exercise training (RT) 
on counteracting sarcopenia is quite well established,11 12 
and the effect of protein supplementation alone has also 
been documented.13 Less well studied is the potential 
benefit of a higher protein intake or supplementation as 
an addition to offering RT among older adults. A recent 
systematic review by Malafarina et al13 and a meta-analysis 
by Cermak et al14 have concluded that in older adults, 
protein supplementation increases muscle mass, and in 
some studies also muscle strength, during prolonged 
RT.13 14 However, the evidence is sparse in the frailest 
older adults, who often have a low dietary protein intake, 
and based on findings in systematic reviews, they might 
benefit even more from a combined intervention.14–16 
To our knowledge, no studies have yet investigated the 
effect of protein supplementation in addition to offering 
RT among hospitalised, acutely ill old adults — a popu-
lation at great risk of a rapid functional deterioration. 
Thus, the present study aims at investigating this, and in 
addition, the intervention will continue after discharge 
from the hospital. The novelty of this study is twofold. 
First, the intervention involves hospitalised older adults, 
and second, the intervention continues after discharge. 
To the best of the authors’ knowledge, previous studies 
were only performed in one setting.
MEthods And AnAlysIs
study design
The study design is a block-randomised, double-blind, 
placebo-controlled, multicentre intervention study. A 
total of 165 participants will be included consecutively 
from the medical departments of three hospitals in 
the capital region of Denmark (Gentofte and Herlev 
University Hospital and Rigshospitalet-Glostrup, n=55 
from each place). Recruitment takes place a maximum 
of 72 hours after admission. After inclusion, partici-
pants will be randomly allocated (1:1) to receive either 
protein-enriched, milk-based supplements (whey 
protein) or an isoenergetic placebo product, as a supple-
ment to their habitual diet. Both groups follow the same 
RT programme and are daily supplemented with vitamin 
D. The intervention starts at the hospital while admitted 
and continues 12 weeks after discharge. Recruitment and 
data collection started in April 2016 and will end in June 
2018.
study population
Inclusion criteria for participation are: men and women 
aged ≥70 years, able to speak and understand Danish, 
expected length of stay >3 days (evaluated by medical 
staff at the department), ability to stand independently 
for at least 30 s and admission to the medical departments 
of Gentofte Hospital, Herlev Hospital or Rigshospital-
et-Glostrup. Exclusion criteria are: active cancer, renal 
insufficiency (eGFR <30 mL/min/1.73 m2), cognitive 
impairment (not able to comprehend the purpose of the 
study/give informed consent), terminal disease, exclu-
sively receiving enteral or parenteral nutrition, milk/
lactose allergy or intolerance, planning to lose weight/
go on a special diet, planned transfer to other hospi-
tals/departments and pacemaker/other implanted elec-
trical stimulants (due to Bio-Impedance Analysis (BIA) 
measurements). Participants will be withdrawn from 
the study if they die during admission (does not apply 
to subsequent admissions) or are discharged/transferred 
from the medical department before the intervention has 
started.
randomisation and blinding
After collection of baseline measurements and character-
istics, participants are randomised to either the interven-
tion or the control group using sealed, opaque envelopes 
containing a paper with either an ‘A’ or a ‘B’. Each 
hospital site has its own pile of envelopes in order to allow 
for block randomisation. Within each site, 10 A’s and 10 
B’s (20 in total) are put in the pile over three rounds to 
ensure a more even allocation of participants in the two 
groups at any time. Participants, hospital staff and study 
investigators will all be blinded towards the randomisa-
tion. If a situation arises where unblinding may be consid-
ered for the benefit of the participant, this will be decided 
on an individual basis taking the specific situation into 
account. Enrolment and randomisation are performed 
by study investigators.
Intervention
Protein-enriched, milk-based supplements and placebo
Depending on their allocation, participants will receive 
either a protein-enriched, milk-based supplement 
beverage (Arla Foods: 781 kJ, 10.5 g whey protein concen-
trate and 0.5 g casein, 10 g fat and 13 g carbohydrate 
per 100 mL) (intervention group) or an isoenergetic 
placebo beverage (Arla Foods: 797 kJ, 0.6 g protein, 10 g 
fat and 24 g carbohydrate per 100 mL) (control group). 
The amino acid profile of the intervention product is 
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shown in online supplementary table 1. Both products 
have a flavour of raspberry and come in ready-to-drink 
preparations. From January 2017 and on, the protein-en-
riched, milk-based supplement will have vitamin D added 
in amounts of 1.125 µg per 100 mL. During the whole 
study period (while hospitalised and 12 weeks postdis-
charge), the participants will be instructed to drink a 
total of 250 mL per day, divided into two servings of 
125 mL. Thus, the intervention group will get a total 
of 27.5 g extra protein per day, equal to 26.25 g whey 
protein containing a total of ~2.5 g leucine. This amount 
of protein supplementation is chosen, based on previous 
studies finding positive effects from similar or smaller 
dosages.17–19 Furthermore, protein supplementation is 
satiating, and if given in higher amounts, might compro-
mise habitual food intake to a great extent, especially 
among older adults with low appetite. The total dosage is 
divided into two servings (breakfast and next cold main 
meal), as research indicate that 25–30 g of high-quality 
protein is needed per main meal to maximally stimulate 
postprandial protein synthesis.8 The beverages come in 
white bottles with either a ‘group A’ or ‘group B’ label. 
While hospitalised, the timing of the intake is as follows: 
one serving at breakfast (or at lunch, if not consumed 
at breakfast for any reasons, for example, fasting neces-
sary, or if the RT is performed right after breakfast) and 
one serving directly after the RT. In the 12 weeks after 
discharge, the participants will be instructed to drink 
one serving at breakfast and one serving with the next 
cold main meal, irrespective of the meal is eaten at lunch 
or at dinner time. If the participants forget to drink the 
beverages at the specific times, they will be told to drink 
it when they become aware of it. The participants will 
not be instructed to make other dietary changes during 
the study period. If participants are prescribed/recom-
mended by hospital staff to take oral nutritional supple-
ments, this is not an exclusion criterion, but participants 
will be instructed to take any additional supplements on a 
given day only after intake of the ‘study beverages’. If for 
some reason (eg, uncontrolled diabetes or severe reduc-
tion of habitual food intake) the participant is advised by 
medical doctors/nutritional therapists to stop taking the 
supplement, this advice will always be followed.
Vitamin D supplements
Vitamin D supplementation has been shown to have an 
independent effect on muscle.20 To reduce the poten-
tial confounder of a large difference in intake of vitamin 
D between groups, all participants will get vitamin 
D supplements handed out after enrolment and be 
instructed to take a supplement of 20 µg/day (two tablets 
of 10 µg), as recommended by the Danish National 
Board of Health.21 Exceptions to this are those partici-
pants whose serum vitamin D levels have been measured 
to ≥100 nmol/L at the time of study inclusion to avoid 
reaching toxic levels. The participants have to register 
their intake of vitamin D in a diary along with their intake 
of the intervention products. Also, at the last visit in study 
week 12, the number of tablets left in the container will be 
counted to verify the registrations. If participants already 
take vitamin D supplements in combination tablets with 
other vitamins and/or minerals corresponding to 20 µg/
day or more, they will be instructed to keep taking their 
own tablets and register this. The exact amount of vitamin 
D in these tablets will be recorded. An average intake of 
vitamin D per day during the intervention period will be 
used to compare if the intake of vitamin D is different 
between the two groups.
Resistance exercise training
The RT programme is developed by experienced phys-
iotherapists and is consistent with the official statements 
from the American College of Sports Medicine on recom-
mendations for RT in older adults.22 It focuses on strength 
training primarily of the big muscle groups of the lower 
limbs and can be performed without any training equip-
ment. One training session consists of three exercises: 
‘lifting-and-lowering the pelvic’ from a crook-lying posi-
tion, ‘sit-to-stand from a chair’ and ‘lifting-and-lowering 
the heels’ in a standing position, that is, performing heel-
raises. All exercises are performed in three sets, aiming 
at 10 repetitions, pursuing an intensity of 8–12 repetition 
maximum. The repetition velocity will be performed at 
the participants own preferred speed. There will be a time 
interval of 1–3 min between sets and exercises, depending 
on the individual need for rest. Each of the three exercises 
can be performed in five different modes (A–B–C–D–E), 
graduated in terms of increasing resistance, by applying 
the participants’ own body weight and different starting 
positions. Thus, the programme can be individualised 
corresponding to the participants’ abilities, and adjust-
ments will be made to ensure progression. The illustrated 
RT programme can be seen in online supplementary 
figure 1. Participants can be asked to leave out a specific 
exercise if there are safety concerns (eg, severe dizziness 
or worsening of a condition) or if they experience pain 
related to performing a certain exercise.
While admitted to hospital, supervised RT is offered 
daily by physiotherapists in addition to the standard of 
care. After discharge, the participants are encouraged to 
perform the same RT programme as self-training four 
times per week. They will be instructed to have at least 
24 hours between training sessions. During the hospital 
stay, it is expected that the participants have a very limited 
amount of physical activity besides the RT programme 
offered and that the intensity by which they can perform 
the RT is rather low. This is why the frequency of the RT 
differs between the hospital and discharge setting. To 
instruct the participants in regard to the RT and to ensure 
progression (or regression if necessary), they receive 
follow-up home visits by a physiotherapist in study weeks 
1, 3, 6, 9 and after discharge from any readmissions. The 
adjustments are made after standardised procedures.
Participants who are discharged with a plan of rehabili-
tation including ambulatory training at a centre or super-
vised training at home, to be provided by their municipally, 
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will be asked to perform the full RT study programme 
until their rehabilitation programme starts up (a wait of 
2–6 weeks is normal). Each training session performed 
as part of a rehabilitation programme will replace one 
self-training session of the RT study programme. The 
same applies if participants are discharged from the 
hospital directly to a 24-hour rehabilitation centre and 
they are performing RT in their regimen. This is to allow 
for proper restitution. The offer of supervised training 
applies only to the first hospital stay, but if readmitted to 
hospital, participants will be encouraged to do the RT 
themselves to the extent possible.
Compliance
While hospitalised, the participants will get the product 
handed out along with the vitamin D supplements. 
Investigators and physiotherapists register overall study 
compliance, that is, daily ingestion of the intervention 
or placebo supplements (time for handout and amount 
ingested), vitamin D (dose, yes/no) and performance 
of the RT (number of sets and repetitions for each exer-
cise). Empty bottles are saved so that study investigators 
can verify the amount of intervention product consumed.
After discharge, the amount of intervention or placebo 
supplement consumed, and the RT performed for each 
participant will be assessed by daily records in a ‘beverage 
and exercise diary’, specifically designed for the study and 
handed out to be filled in by the participants. The partic-
ipants, for example, with help from their relatives, are 
asked to daily register the amount of beverage consumed: 
0%, 25%, 50%, 75% or 100% of each of the two servings 
by ticking of the corresponding circular illustration, along 
with ticking of the intake of vitamin D. Participants also 
have to register execution of the RT and specify for each 
of the three exercises the number of sets and repetitions 
performed. If they are exercise training at a rehabilita-
tion centre, this can be registered in the relevant boxes. 
In case of deviations, four prespecified explanations are 
given that they can tick off, both in regard to the intake 
of supplements and the execution of the RT. To verify 
the participants’ records, they are asked to save and store 
empty bottles, which will be picked up by investigators on 
days with home visits. At the same time study investigators 
will help the participants to retrospectively fill out any 
missing registrations. Participants who are discharged to 
a 24-hour rehabilitation centre will get the intervention 
products handed out by the staff who will also save empty 
bottles. On the first visit after discharge, the participants 
will receive thorough instructions on how to register 
compliance in the ‘beverage and exercise diary’, and 
upcoming visits will be planned. Both groups will receive 
daily standard messages on their cell phone (if they have 
one and agrees to this) and weekly phone calls, kindly 
reminding them to consume the supplement and vitamin 
D, perform the RT and register compliance. Further-
more, as part of the phone call, they will be asked about 
compliance and any deviations or, for example, upstart of 
training at a rehabilitation centre will be registered and 
validated/compared later on with their own diaries, and 
they will be reminded of upcoming home visits.
outcome parameters
The baseline characteristics will be collected at inclu-
sion to the study. To standardise the endpoint measures, 
especially that of LBM, these will be assessed 1.5–2 hours 
after a light breakfast. Thus, if inclusion happens in the 
afternoon, then baseline measurements will be assessed 
the following day, prior to any study interventions. The 
measurements will be assessed in a predefined order to 
reduce fatigue and follow standardised procedures, and 
they will be repeated within 72 hours after discharge and 
12 weeks (±2 days) after discharge. If possible, before 
each endpoint examination, the participants will be asked 
to consume a breakfast, similar to that consumed at the 
hospital before the baseline measurements. The assess-
ments after discharge will be performed in the partic-
ipants’ own home. Follow-up assessments, including 
only admission to hospital and mortality, will be assessed 
6 months after the intervention period. In general, if 
participants are readmitted to hospital, if possible, assess-
ments will be performed there and otherwise at a replace-
ment visit after discharge. All data collection is performed 
by study investigators. Table 1 gives an overview of the 
study period and the different time points for meetings 
and tests.
Primary endpoint
Lower extremity muscle strength is measured by the 30 s 
chair-stand-test (30 s CST). The test exists in both a stan-
dardised and a modified version. The standardised 30 s 
CST measures the number of times the participant can 
rise and sit from a standard chair (height of 43–45 cm) in 
30 s with the arms folded across the chest, starting from 
a sitting position. Only full stands will count,  that is, 
full extension of the knees and hips. Those who cannot 
stand from the chair without using the arm rest will get 
a score of 0.23 In the modified 30 s CST, the participant 
is allowed to use the arm rests.24 If participants are only 
able to perform the modified version at baseline, for the 
following assessments, they will be asked to do the same. 
If they are able to do the standardised version, they will 
be asked to do that as well after a 15 min rest. A change of 
2.0–2.6 stands is considered to be clinically relevant based 
on data from a population of older adults with hip and 
knee osteoarthritis.25
secondary endpoints
Total, appendicular and trunk LBM (kg and per cent) is assessed 
by Bio-Impedance-Analysis (BIA) using the portable 
InBody-230 body composition analyser (dual frequency 
(20 kHz and 100 kHz), tetra polar 8-Point Tactile Elec-
trode System (InBody, Copenhagen, Denmark)). Direct 
segmental measurement technology is used, meaning 
that no calculations, and thus empirical factors and 
imputations, are needed. Various factors can affect BIA 
measurements such as previous exercise, body position, 
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skin temperature, dietary intake and hydration state.26 
Thus, in order to standardise the measurements, these 
will be performed in the morning 1.5–2 hours after a light 
breakfast and bladder emptying (preferably also bowel 
emptying) and before any exercise. Participants will be 
asked to wear light clothes and no shoes. They will be 
instructed to stand upright with the feet on the build-in 
electrodes embedded in the scale platform, grasp the 
handles of the analyser while spreading the arms as much 
as they can and look straight ahead. The reliability of the 
InBody-230 body composition analyser will be measured 
and used to establish the threshold of change needed 
beyond measurement error.
Hand grip strength (HGS) is a proxy measure of upper 
extremity strength and is measured in kg using the second 
handle position with a DHD-1 Digital Hand Dynamom-
eter (Saehan Medical, 2012, Roskilde, Denmark). The 
second handle position is recommended as a standard 
position, as it is suitable for most hand sizes. An investi-
gator will instruct the participants to be seated with their 
feet on the ground, shoulders adducted and neutrally 
rotated, elbow flexed at a 90° angle and supported on 
the armrests of the chair or a table and forearm and wrist 
in neutral position, as recommended by Roberts et al.27 
They will be asked to perform three maximum force trials 
with their dominant hand, and the highest value will be 
registered. They will be instructed to squeeze the handle 
as hard as they can for 5 s, and the test will be repeated 
within 15 s.
Four-meter gait speed (4 m GS) is used to assess the usual 
gait speed (m/s) over a short distance. Participants 
will be placed behind a starting line and instructed to 
start walking at their usual pace after the investigators 
command. To reduce the effect of acceleration and 
deceleration, each participant will be instructed to walk 
towards a visual goal for 5 m. The time will be started after 
the participant has walked 0.5 m and stopped after 4.5 m, 
counted from the first footstep that crosses the 4 m start 
line and end line, respectively. The fastest of two attempts 
is recorded. If it is not possible to establish a 5 m test track, 
a shorter track with a minimum length of 3.5 m in total 
will be used instead, and this will be registered as bias.28 29 
The participants are allowed to use a gait aid, which will 
be registered as well. In sedentary older adults, a clinical 
relevant difference is found to be 0.03–0.05 m/s, while 
0.08 m/s is found to be a substantial relevant difference.30
Functional ability is measured using the modified Barthel 
Index (Barthel-100).31 32 The Barthel-100 contains 10 
measures of everyday and mobility activities, and the 
ability to master these activities reflects the level of 
Table 1 Flow chart of the study period, including meetings and tests
Flow chart of study period Baseline
Inhospital 
intervention Posthospital intervention* Follow-up
Study week no. – – 1 3 6 9 12 38
Meetings including tests 1+2 – 3 4 5 6 7 – 
Inclusion and exclusion criteria X
Informed consent X
Baseline characteristics X
Baseline endpoint assessment† X
Randomisation X
LOS (inhospital intervention period) X
Dietary registration X
(4 days in total)
Daily compliance registrations X X
Endpoint assessment† X‡ X§
Exercise adjustments X X X X
Weekly phone call X
24-hour dietary interview X X X X
Exercise interview X X X X
Evaluation questionnaire X
Delivery of intervention products X
(ongoing basis)
X
(deliveries after appointment)
Collection of empty intervention bottles X X X X X
Readmissions, LOS and mortality X X
*Assessed 1.5–2 hours after a light breakfast (preferably the same meal every time).
†Assessed within 72 hours after discharge.
‡Assessed 12 weeks (±2 days) after discharge.
§Assessments and meeting are taking place where the participants live.
LOS, length of hospital stay.
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functioning. Each measure has five levels of functioning, 
and for all 10 measures, a maximum of 100 points can 
be achieved, corresponding to fully independent. The 
Barthel-100 will be scored by the investigators and rated 
based on the amount of assistance required to complete 
each activity or by observing, and clarifying questions will 
be asked when necessary.
Mobility is assessed by De Morton Mobility Index 
(DEMMI), which provides a 15-item unidimensional 
measure of mobility across the spectrum from bed bound 
to independent mobility, specifically developed for geri-
atric patients.33 It has five categories in which the partici-
pants are tested: bed (three test scores), chair (three test 
scores), static balance (four test scores), walking (two 
test scores) and dynamic balance (three test scores). A 
total test score from 0 to 19 can be achieved, and this raw 
score is converted to an interval DEMMI score from 0 to 
100, where 100 represents independent mobility. In older 
acute medical patients, the clinical relevant difference is 
found to be 10 points on the converted scale.33
Cognitive function is measured using the Mini-Mental 
State Examination (MMSE), which consists of small 
simple tasks to elucidate eight different cognitive func-
tions: orientation, episodic memory, concentration, func-
tion of language, practical exercise, reading skills, writing 
skills and visual-spatial construction. The performances 
are scored to give a raw score ranging from 0 to 30, where 
30 represent the best/optimal function.34
Social support is evaluated using registrations of home 
care (yes/no; if yes, then divided into practical help, 
personal care and both) and residence (own home, 
nursing home/assisted living facility and 24-hour rehabil-
itation facility).
Use of gait aid is registered as yes (including specific gait 
aid), no or cannot walk.
Length of hospital stay (LOS) corresponds to the 
inhospital intervention period (days from recruitment 
until discharge), which is registered from the electronic 
patient register.
Readmission to hospital and mortality: readmission to 
hospital is registered both with regard to frequency and 
the total LOS from the electronic patient register. These 
data are summed up after the intervention period and 
after the follow-up period, respectively.
Health-related quality of life (QOL) is assessed by 
using the generic questionnaire, EuroQol-5Dimen-
sions-3Level (EQ-5D-3L).35 The questionnaire is self-re-
ported and reflects the participant’s current situation.
Scores for the EQ-5D-3L are generated from the ability 
of the individual to function in five dimensions: mobility, 
pain/discomfort, self-care, anxiety/depression and usual 
activities. Each dimension has three possible answers: no 
problem, some problems and major problems. Also, the 
participants rate their current health state on a visual 
analogue scale ranging from 0 to 100 (reflecting a health 
state from ‘worst’ to ‘best’).
Body weight is measured to the nearest 0.1 kg using 
the BIA equipment InBody-230 and follows the same 
standardised procedures as described under the endpoint 
‘muscle mass’.
Product evaluation questionnaire: both the intervention 
and placebo product is evaluated using a self-report ques-
tionnaire. The evaluation questionnaire concerns overall 
liking, side effects related to consumption, taste fatigue, 
texture, dosage and manageability.
Control for confounders: other registrations and precautions
Actions are taken to actively reduce or register known 
or possible confounders. Thus, at baseline, confounders 
such as admission diagnosis, chronic diseases, nutri-
tional risk (NRS 2002),36 sarcopenia,3 37 depression38 and 
mobility39 40 are evaluated, among others. Nutritional risk 
is determined based on a combination of factors: unin-
tended weight loss within the last 3 months, loss of appe-
tite within the last week, body mass index, disease severity 
and age. Patients screened to be at risk are expected 
to benefit from nutritional intervention. Sarcopenia is 
assessed according to the definition proposed by the Euro-
pean Working Group on Sarcopenia in Older People. 
This is based on the assessments of LBM (measured by 
BIA), muscle strength (measured by HGS) and phys-
ical performance (measured by 4 m GS). Furthermore, 
besides register vitamin D intakes, throughout the study, 
the following two measures are collected on an ongoing 
basis.
Protein and energy intake
During hospitalisation, the participants’ protein (g/kg) 
and energy (kJ/kg) intake will be registered for 4 days 
or shorter if the participants are discharged. The hospi-
tals’ food and drink registration schemes will be used. 
Participants will be asked to fill in the food registration 
schemes themselves with help from the nurses and study 
investigators. The participant’s body weight at inclusion 
will be used to calculate the intake per kg body weight. 
During the 12-week posthospital intervention the partic-
ipants protein and energy intake will be estimated based 
on the average of four 24-hour dietary recall interviews 
performed at study week 3, 6, 9 and 12 at home visits, or 
by phone if the participant are no longer compliant in 
the study with regard to the intervention products and 
the RT. As the home visits will be planned in collaboration 
with the participants and has to be fitted into other study 
tasks and visits, these practicalities decide what day of the 
week the recall interview is covering. To minimise the risk 
of recall bias, a checklist of specific foods and beverages 
will be used to verify the reported intake. Furthermore, 
when interviewing face to face, picture series of portion 
sizes of different foods will be used to estimate the 
amounts ingested.41 The foods and drinks will be entered 
in the software program Madlog Vita to calculate the 
intake of protein (g) and energy (kJ). Four days of regis-
tration/dietary recalls are considered adequate to assess 
this information with a high correlation.42 An average of 
the participant’s body weight after discharge and in week 
12 will be used to calculate the intake per kg body weight. 
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The cut-off for suspecting under-reporting will be eval-
uated retrospectively on an individual basis taking any 
illness, readmissions, loss of body weight, activity level and 
so on into account.
Daily activity level
In a semistructured interview, the participants are 
asked about exercise-related activities besides the RT 
programme. This is reported four times after discharge 
in study week 3, 6, 9 and 12 at home visits or by phone 
if the participant is no longer compliant in the study 
with regard to the intervention products and the RT. 
Depending on the answers given, the participants will be 
divided into activity levels from 1 to 5 after predefined 
criteria, inspired by Saltin and Grimby.43 The scale is 
ordinal, and activity level 1 represents the least active 
and level 5 represents the most active. It is the time used 
on different activities and the intensities of these (low, 
moderate or high) that determine the activity level.
statistics
Power calculation
The primary endpoint is muscle strength measured by 
the 30 s CST. The clinical relevant difference for this test 
is found to be 2.0–2.6, when assessed in older populations 
with hip and knee osteoarthritis.25 Jones et al23 has used 
the standardised 30 s CST on community-dwelling older 
people and found an SD of 3.0 and 3.6 for people in the 
age range of 70–79 years and 80–89 years, respectively.23 
This gives a pooled SD of 3.31, which is used in this power 
calculation, and it corresponds well with measures of SD 
found in the modified test version.44
In order to be able to detect a difference of 2.0, with 
a power of 80% and a two-sided alpha error of 0.05, the 
required sample size is 80 participants in each group, 
given an anticipated combined rate of dropouts and 
non-compliance of 45%. This rate is chosen since studies 
with resistance training in older adults both while hospi-
talised45 and in a community-dwelling setting46 have expe-
rienced dropouts of 30%. Moreover, an additional 15% is 
added to account for participants with a low compliance 
to the intervention to be able to maintain the statistical 
power of the study in the intention-to-treat analysis as 
well as in the per-protocol analysis. For practical reasons, 
if possible within the time schedule, 55 participants will 
be included at each of the three sites, resulting in a total 
inclusion of 165 participants.
Feasibility of recruitment and sample size
The three hospitals where recruitment is going to take 
place had between 525 and 687 geriatric patients in year 
2014, with a median LOS ranging from 8 to 11 (5–16) 
days. The median age for women was in the range of 
84–87 years and 83–84 years for men.47 To meet the time-
table, the expected recruitment rate is a minimum of 
two participants per week which, based on these data, is 
considered realistic.
Statistical tests
The primary analysis will be performed by the intention-
to-treat principle. In addition, a predefined per-protocol 
analysis will be performed including participants with 
a high compliance only (consumption of the interven-
tion product ≥75%). Furthermore, endpoints will be 
compared adjusting for randomisation bias (defined 
as P<0.05 between groups) and confounding factors 
(total activity level and total protein and energy intake). 
Analysis will be done both with and without imputa-
tion techniques for missing values, but dropouts will 
be encouraged to participate in follow-up examina-
tions, including interviews concerning dietary intake 
and activity level. Sensitivity analysis will be performed 
without outliers, defined as a value of 3 SD above or 
below the mean. To investigate whether the interven-
tion will have different impacts in different groups of 
patients, for example, those who are at nutritional risk or 
sarcopenic, subgroup analysis will be performed looking 
at treatment effect in the subgroups and interactions 
between treatment effect and subgroups. Furthermore, 
observational analysis will be performed, investigating 
the importance of total protein and energy intake and 
total activity level on outcome measures. The two groups 
will be compared looking at the hospitalisation interven-
tion period and the 12-week postdischarge intervention 
period both separately and as a whole.
Results will be presented as median (range) or mean 
(SD or 95 % CI) and number (absolute frequencies) 
for continuous and categorical variables, respectively. 
Inspection for normality will be done by visual inspection 
(Q–Q plot), and parametric or non-parametric statis-
tical tests will be used in accordance with the distribu-
tion of the variables. Statistical comparisons will be made 
between the two groups by using the Mann-Whitney U-test 
or Student’s t-test for continuous variables and the X2 test 
or Fisher’s exact test (in case of expected cell count <5) 
for the comparison of categorical variables. Analysis of 
covariance will be used for continuous outcomes and 
binary logistic regression for binary outcomes if/when 
adjusting for confounders and testing for subgroup inter-
action. The Spearman rank correlation test or general 
linear model will be used to test for correlations between 
independent variables. All tests are two tailed, and an 
alpha level of P<0.05 will be used to determine statistical 
significance in all analyses.
With regard to the primary endpoint, 30 s CST, the 
changes in performance from baseline (both with and 
without pooling standardised and modified test results) 
will be measured and compared between the two groups. 
Furthermore, performance will be scored into one of 
three categories: (1) ability to rise from the chair with 
arms folded across the chest; (2) ability to rise from the 
chair using the arm rest; and (3) not able to rise inde-
pendently from the chair. Also, compared with baseline, 
performance will be scored into either ‘better’, ‘worse’ or 
‘unchanged’.
group.bmj.com on February 6, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
8 Gade J, et al. BMJ Open 2018;8:e019210. doi:10.1136/bmjopen-2017-019210
Open Access 
EthICs And dIssEMInAtIon
The study will be conducted in accordance with the 
principles of the World Medical Association Declaration 
of Helsinki. Thus, precautions will be taken to protect 
the privacy and confidentiality of research subjects. 
The study is registered in the  clinical. trial. gov database 
(NCT02717819). Any amendments to the protocol will be 
made public at  clinical. trial. gov. All participants receive 
written and oral information from study investigators 
about all relevant aspects of the study before making deci-
sion about participation, and they are informed that they 
can withdraw from the study at any time. The participants 
receive no payment and will have no expenses associated 
with participation in the study. There are no expected 
risks associated with participation, and we expect each 
participant to benefit from the RT. The results of the study 
will be published in international peer-reviewed journals 
and presented at national and international congresses 
and symposiums.
dIsCussIon
This study investigates the effect of protein supplemen-
tation in addition to offering RT among older adults 
while admitted to the geriatric ward and after discharge. 
The acutely ill ‘geriatric patient’ is a heterogeneous 
patient group with various (non-surgical) diseases and 
often existing comorbidities. The goals are to counteract 
sarcopenia, maintain or improve physical function and 
reduce healthcare costs in this specific population. Thus, 
with this study, we wish to add knowledge about effective 
secondary prevention and interdisciplinary rehabilita-
tion strategies to the large population of acutely ill older 
adults admitted to hospital. The eligibility criteria are 
very broad; however, the weakest patients (no stand func-
tion) are excluded, as these will not be able to participate 
in a RT programme and perform the endpoint measure-
ments. The participants in the current study are included 
within 3 days of admission. It is possible that the weakest 
geriatric patients with no stand function, currently 
excluded, will gain their stand function later during 
their hospitalisation (>3 days). Thus, the results from 
the current study may also be relevant to this group of 
patients, although not examined. A common confounder 
is that people agreeing to participate in an intervention 
trial are more motivated to lifestyle changes, which is an 
important factor for the compliance and possible success 
of this intervention.
Use of placebo beverages allows blinding of partici-
pants and researchers. Thus, performance and detection 
bias are minimised. Another strength is the randomisa-
tion procedure, which will limit selection bias and hope-
fully balance different confounders that could potentially 
influence the results. The multicentre trial design 
furthermore increases the generalisability of the results. 
The activity and dietary interviews are conducted in order 
to be able to correct statistically for differences in protein 
intake and activity levels between groups. In addition, it 
will also enable us to investigate the importance of overall 
protein and energy intake on the results.
The majority of older adults in Denmark take vitamin 
D supplements as recommended by the Danish Health 
Authority.21 Studies have shown that vitamin D has an 
independent positive effect on muscle strength.48 In order 
to investigate the effect of the protein supplementation 
alone, vitamin D supplements will be given to all partici-
pants with serum vitamin D levels ≤100 nmol/L at inclu-
sion to ensure similar vitamin D intakes. Another reason 
for ensuring that all participants are supplemented with 
vitamin D is that the protein-enriched beverage approxi-
mately halfway through the intervention period will have 
vitamin D added to the product. However, the fortifica-
tion level is quite low, adding an extra amount of only 
3.5 µg vitamin D per day from the beverages which, for 
example, corresponds to 13 g of salmon.49 Also, compared 
with the daily vitamin D supplementation of minimum 
20 µg (some older adults take even higher amounts, as 
prescribed by their doctor), it is considered insignificant.
In regard to ensure compliance to the RT programme, 
it is a weakness of the study that the RT at home after 
discharge is not supervised. However, an aim of the 
current study is to test the effect of an interdisciplinary 
rehabilitation regime that is cost-effective and could 
easily be implemented. Supervised RT four times per 
week would have required a lot of resources, which most 
likely would not be possible to implement in the real 
world. If a positive effect is found from an intervention 
consisting only of extra protein consumption and self-
training after discharge, then potential implementation 
in clinical practice will be more feasible and likely. The 
current study can also give valuable insights into which 
subgroups of the geriatric patients that would be able 
to benefit from a rehabilitation regime based on self-
training and protein intervention. The high rate of read-
missions to hospital among older adults50 indicates that 
there is room for improvement in regard to secondary 
prevention strategies.
The specific endpoints included in the current study 
were chosen in order to be suitable, feasible and valid 
for this specific population of older adults. Thus, a low 
amount of missing data is expected due to low feasi-
bility. The 30 s CST, DEMMI and Barthel-100 are part of 
the normal routine tests for geriatric patients admitted 
to the medical departments (they are included in The 
Danish National Geriatric Data Base), and all tests and 
questionnaires are developed and/or validated in older 
adults.28 32–34 Furthermore, the Danish Board of Health 
recommends the use of 30 s CST, 4 m GS, MMSE and 
EQ-5D-3L as tests in older geriatric patients.29 Also, 
LBM, measured by BIA, has been proposed as a feasible 
measurement tool in this population,3 51 and a portable 
BIA is a practical tool suitable for home visits.
Specifically for the primary endpoint, the 30 s CST 
has been shown to be a reliable and valid indicator 
of lower body strength in generally active, communi-
ty-dwelling older adults when validated against maximum 
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weight-adjusted leg-press performance.23 The stan-
dardised 30 s CST version has been shown to have low 
feasibility (54%) in acutely admitted old medical patients 
and to have lower inter-rater reliability than in medically 
stable patients. However, the modified 30 s CST has been 
shown to be both feasible and having a high inter-rater 
reliability.28 Thus, we believe that all participants will be 
able to perform either the standardised or the modified 
version, supported by the inclusion criteria, that only 
patients who can stand independently are recruited, 
eliminating those in poorest conditions. This is also in 
accordance with experience from our former interven-
tion studies performed in geriatric patients52 53 and also 
applies to the other secondary endpoints.
For the secondary endpoint, LBM measured by 
a portable BIA, Moon et al51 have shown that single 
frequency BIA in elderly men and women (72 men and 
women, >65 years) correlate well with dual-energy X-ray 
absorptiometry (DXA) measurements, as well as the 
four-compartment model, at single time points as well as 
for tracking changes in LBM. They concluded that DXA 
and BIA can be used interchangeably as valid methods 
to measure LBM when looking at a population basis of 
more than 15–22 people.51 Furthermore, Karelis et al54 
have validated the portable, dual-frequency InBody-230 
BIA against DXA in a healthy mixed population (145 
men and women, 44.6±20 years) and found a significant 
high correlation when looking at fat mass, percent body 
fat and total LBM.54 Thus, it is expected that using the 
InBody-230 BIA equipment, besides being practical in 
regard to home visits, will be a reasonable valid method 
to assess total muscle mass in a population of 165 older 
adults.
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